New polymorphic forms of the 3- (1- {3- [5- (1-methyl-piperidin-4-ylmethoxy) -pyrimidin-2-yl] -benzyl} -6-oxo-1,6-dihydro hydrochloride salt -piridazin-3-yl) -benzonitrile and production processes thereof
BECKER, AXEL,KUEHN, CLEMENS,SAAL, CHRISTOPH,SCHADT, OLIVER,DORSCH, DIETER,BOKEL, HEINZ-HERMANN,STIEBER, FRANK,DONINI, CHRISTINA
申请号：
ES09764204
公开号：
ES2522629T3
申请日:
2009.12.04
申请国别(地区):
ES
年份:
2014
代理人:
摘要：
3- (1- {3- [5- (1-Methyl-piperidin-4-ylmethoxy) -pyrimidin-2-yl] -benzyl} -6-oxo-1,6-dihydro-pyridazin-3 hydrochloride solvate - il) -benzonitrile excluding the H2 crystalline modification of 3- (5 1- {3- [5- (1-methylpiperidin-4-ylmethoxy) -pyrimidin-2-yl] -benzyl} -6-oxo hydrochloride monohydrate -1,6-dihydro-pyridazin-3-yl) -benzonitrile: Form H2: ** Formula **Solvato de clorhidrato de 3-(1-{3-[5-(1-metil-piperidin-4-ilmetoxi)-pirimidin-2-il]-bencil}-6-oxo-1,6-dihidro-piridazin-3- il)-benzonitrilo excluyendo la modificación cristalina H2 del monohidrato de clorhidrato de 3-(5 1-{3-[5-(1-metilpiperidin- 4-ilmetoxi)-pirimidin-2-il]-bencil}-6-oxo-1,6-dihidro-piridazin-3-il)-benzonitrilo: Forma H2:**Fórmula**
